We are live on ! Find out more
HCMT

Highland Capital Management (Texas) Portfolio holdings

AUM $39M
This Fund
S&P 500
This Quarter Est. Return
-13.21%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.43B
AUM Growth
-$1.48B
Cap. Flow
-$781M
Cap. Flow %
-22.76%
Top 10 Hldgs %
29.46%
Holding
380
New
70
Increased
61
Reduced
81
Closed
119

Sector Composition

Rank Sector Weight
1 Healthcare 16.42%
2 Technology 11.74%
3 Energy 8.78%
4 Consumer Discretionary 5.86%
5 Industrials 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFNX
151
DELISTED
Pfenex Inc.
PFNX
$4.42M 0.13%
+294,167
New +$5.98M
TDC icon
152
Teradata
TDC
$2.58B
$4.38M 0.13%
151,350
NTAP icon
153
NetApp
NTAP
$39B
$4.37M 0.13%
147,700
ARWR icon
154
Arrowhead Research
ARWR
$12.5B
$4.19M 0.12%
+726,634
New +$4.57M
ELGX
155
DELISTED
Endologix Inc
ELGX
$4.14M 0.12%
+33,769
New +$4.58M
DLNG icon
156
Dynagas LNG Partners
DLNG
$140M
$4.13M 0.12%
310,242
+80,000
+35% +$1.14M
ADPT
157
DELISTED
Adeptus Health Inc
ADPT
$4.1M 0.12%
50,731
+2,767
+6% +$286K
CMLS
158
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$4.03M 0.12%
716,095
RLYP
159
DELISTED
RELYPSA INC COM
RLYP
$4.02M 0.12%
216,948
-81,300
-27% -$2.23M
CHRW icon
160
C.H. Robinson
CHRW
$17.3B
$4.01M 0.12%
+59,206
New +$3.97M
MCHI icon
161
iShares MSCI China ETF
MCHI
$6.42B
$3.94M 0.11%
90,000
EWH icon
162
iShares MSCI Hong Kong ETF
EWH
$1.23B
$3.82M 0.11%
200,000
KND
163
DELISTED
Kindred Healthcare
KND
$3.54M 0.1%
225,000
-887,083
-80% -$17.9M
FATE icon
164
Fate Therapeutics
FATE
$322M
$3.5M 0.1%
657,097
-265,333
-29% -$1.81M
LAB icon
165
Standard BioTools
LAB
$310M
$3.31M 0.1%
408,777
+7,432
+2% +$117K
CHRS icon
166
Coherus Oncology
CHRS
$192M
$3.25M 0.09%
162,400
-40,400
-20% -$1.23M
ECYT
167
DELISTED
Endocyte, Inc. Common Stock
ECYT
$3.19M 0.09%
697,369
-284,600
-29% -$1.49M
UHS icon
168
Universal Health Services
UHS
$10.5B
$3.12M 0.09%
25,000
KMI icon
169
Kinder Morgan
KMI
$69.9B
$2.91M 0.08%
105,168
+4,410
+4% +$146K
STRM
170
DELISTED
Streamline Health Solutions
STRM
$2.81M 0.08%
81,678
+64,826
+385% +$2.61M
NBRV
171
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$2.76M 0.08%
+1,162
New +$3.08M
ATHN
172
DELISTED
Athenahealth, Inc.
ATHN
$2.55M 0.07%
+19,133
New +$2.5M
LHCG
173
DELISTED
LHC Group LLC
LHCG
$2.37M 0.07%
52,932
-56,300
-52% -$2.47M
SPY icon
174
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$2.3M 0.07%
+12,000
New +$2.43M
HTH icon
175
Hilltop Holdings
HTH
$2.22B
$2.29M 0.07%
115,874
+13,743
+13% +$294K

Similar funds

Highland Capital Management (Texas)'s Q3 2015 Portfolio in Review

As of Q3 2015, Highland Capital Management (Texas) held 380 positions worth $3.43B, down 30% from $4.91B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Highland Capital Management (Texas) withdrew a net $781M in Q3 2015, closing 119 positions and reducing 81 holdings. Its most notable exit was McKesson, an estimated $27.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Energy.

Against the trend, Highland Capital Management (Texas) opened a new position in Amazon worth $23.4M.

  • Highland Capital Management (Texas)'s largest Q3 2015 buy was Amazon: 912,300 shares worth $23.4M.
  • Highland Capital Management (Texas) added most to Patterson Companies, Inc. in Q3 2015, an estimated $77.8M increase.
  • Highland Capital Management (Texas)'s biggest Q3 2015 reduction was American Airlines Group, cutting an estimated $118M.
  • Highland Capital Management (Texas) fully exited McKesson in Q3 2015, selling an estimated $27.5M.
  • Highland Capital Management (Texas)'s ten largest holdings make up 29% of its $3.43B portfolio in Q3 2015.
  • Highland Capital Management (Texas) opened 70 new positions and closed 119 in Q3 2015.
  • Highland Capital Management (Texas)'s portfolio value fell 30% quarter-over-quarter to $3.43B.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2015, filed 16 Nov 2015.